DAFTAR PUSTAKA

Amelia, A., Nugroho, A., and Harijanto, P.N., 2016. Diagnosis and Management of
Infections Caused by Enterobacteriaceae Producing Extended-Spectrum b-
Lactamase. Acta Medica Indones. -The Indones. J. Intern. Med., 48 (2),
156–166.
Anonim, 2014. ThermoTM ScientificTM BrillianceTM ESBL User Guide. Diunduh
dari http://www.oxoid.com/pdf/oxoid-Brilliance-ESBL.pdf. Pada tanggal
27 Februari 2017.
Anonim, 2016. Beta lactam Pharmacology. Diunduh dari
http://tmedweb.tulane.edu/pharmwiki/. ada tanggal 6 Februari 2017.
Balouiri, M., Sadiki, M., and Ibnsouda, S.K., 2016. Methods for in vitro evaluating
antimicrobial activity: A review. J. Pharm. Anal., 6 (2), 71–79.
Basak, S. and Rajurkar, M.N., 2014. Newer β-Lactamases and E . coli — A Cause
of Concern. In: Shailendra K. Saxena, ed. Trends in Infectious Diseases.
47–72.
Basu, A., Arumugam, U., and Rao, N., 2014. Detection of extended-spectrum ß-
lactamases in members of the family Enterobacteriaceae: comparison of the
Combination Double Disc Test Method and the Etest ESBL. IOSR J. Dent.
Med. Sci., 13 (2), 58–63.
Bereket, W., Hemalatha, K., Getenet, B., Wondwossen, T., Solomon, A., Zeynudin,
A., and Kannan, S., 2012. Update on bacterial nosocomial infections. Eur.
Rev. Med. Pharmacol. Sci., 16 (8), 1039–1044.
Blane, B., Brodrick, H.J., Gouliouris, T., Ambridge, K.E., Kidney, A.D., Ludden,
C.M., Limmathurotsakul, D., Török, M.E., and Peacock, S.J., 2015.
Comparison of 2 chromogenic media for the detection of extended-spectrum
β-lactamase producing Enterobacteriaceae stool carriage in nursing home
residents. Diagn. Microbiol. Infect. Dis., 10–12.
Blanes, J.I.M., 2011. Consensus document on treatment of infections in diabetic
foot. Rev. Esp. Quimioter., 24 (4), 233–62.
Bockstael, K. and Aerschot, A., 2009. Antimicrobial resistance in bacteria. Cent.
Eur. J. Med., 4 (2), 141–155.
Bradford, P.A., 2001. Extended spectrum betalactamase in the 21 century:
characterization, epidemiology, and detection of this important resistant
threat. Clin. Microbiol Rev, 14 (4), 933–951.
Breathnach, A.S., 2013. Nosocomial infections and Infection Control. In: Medicine.
Elsevier Ltd, 557–561.
Casqueiro, J., Casqueiro, J., and Alves, C., 2012. Infections in patients with diabetes
mellitus: A review of pathogenesis. Indian J. Endocrinol. Metab., 16 (1),
S27-36.
Cavalieri, S.J., Harbeck, R.J., McCarter, Y.S., Ortez, J.H., Rankin, I.D., Sautter,
R.L., Sharp, S.E., and Spiegel, C.A., 2005. Manual of antimicrobial
susceptibility testing. Am. Soc. Microbiol., 53–62.
Chadwick, P., Edmonds, M., MsCardle, J., Armstrong, D., Apelqvist, J., Botros,
M., Clerici, G., Cundell, J., Ehrler, S., Hummel, M., Lipsky, B.A., Martinez,

116
 117

J.L.L., Thomas, R., and Tulley, S., 2014. Best Practice Guidelines : Wound
Management in Diabetic Foot Ulcers. Wounds International. Wounds
International.
Chavan, S.K., Gs, K., and Chavan, K.B., 2015a. Bacterial Profile and pattern of
antimicrobial drug resistance in Diabetic foot ulcers at Tertiary care
hospital. Int. J. Med. Reasearch Rev., 3 (1), 97–105.
Cockerill, F.R., Wilker, M.A., and Jeff Alder, 2013. Performance Standards for
Antimicrobial Susceptibility Testing, CLSI, Twenty-first Informational
Supplement. Clinical and Laboratory Standards Institute.
D’Souza, H.A., Campbell, M., and Baron, E.J., 2004. Practical Bench Comparison
of BBL CHROMagar Orientation and Standard Two-Plate Media for Urine
Cultures. J. Clin. Microbiol., 42 (1), 60–64.
Diekema, D.J. and Pfaller, M.A., 2013. Rapid detection of antibiotic-resistant
organism carriage for infection prevention. Clin. Infect. Dis., 56 (11), 1614–
1620.
Drieux, L., Brossier, F., Sougakoff, W., and Jarlier, V., 2008. Phenotypic detection
of extended-spectrum β-lactamase production in Enterobacteriaceae: review
and bench guide. J. Compil. Eur. Soc. Clin. Microbiol. Infect. Dis., 14 (1),
90–103.
Drinka, P., Bonham, P., and Crnich, C.J., 2012. Swab culture of purulent skin
infection to detect infection or colonization with antibiotic-resistant
bacteria. J. Am. Med. Dir. Assoc., 13 (1), 75–79.
Ejaz, H., Ul-Haq, I., Mahmood, S., Zafar, A., and Mohsin Javed, M., 2013.
Detection of extended-spectrum β-lactamases in Klebsiella pneumoniae:
comparison of phenotypic characterization methods. Pakistan J. Med. Sci.,
29 (3), 768–72.
Evans, B.A. and Amyes, S.G.B., 2014. OXA Beta-lactamases. Clin. Microbiol.
Rev., 27 (2), 241–263.
Färber, J., Moder, K.A., Layer, F., Tammer, I., König, W., and König, B., 2008.
Extended-spectrum beta-lactamase detection with different panels for
automated susceptibility testing and with a chromogenic medium. J. Clin.
Microbiol., 46 (11), 3721–3727.
Feraro, J.H.J. and M.J., 2009. Antimicrobial Susceptibility Testing: A Review of
General Principles and Contemporary Practices. Clin. Infect. Dis., 7750,
1749–1755.
Flight, L. and Julious, S.A., 2015. The disagreeable behaviour of the kappa statistic.
Pharm. Stat., 14 (1), 74–78.
Gadepalli, R., Dhawan, B., Sreenivas, V., Kapil, A., Ammini, a. C., and Chaudhry,
R., 2006. A clinico-microbiological study of diabetic foot ulcers in an Indian
tertiary care hospital. Diabetes Care, 29 (8), 1727–1732.
Gazin, M., Paasch, F., Goossens, H., and Malhotra-Kumar, S., 2012. Current trends
in culture based and molecular detection of extended-spectrum-beta-
lactamase harboring and carbapenem-resistant Enterobacteriaceae. J. Clin.
Microbiol., 50 (4), 1140–1146.
Giamarellou, H., 2005. Multidrug resistance in Gram-negative bacteria that produce
extended-spectrum beta-lactamases (ESBLs). Clin. Microbiol. Infect., 11
 118

Suppl 4 (August 2005), 1–16.

Giri, D., 2016. Gram Staining : Principle, Procedure, Interpretation and Animation.
Diunduh dari http://laboratoryinfo.com/gram-staining-principle-procedure-
interpretation-and-animation/. Pada tanggal 13 April 2017.
Giriyapur, R.S., Nandihal, N.W., S, K.B. V, Patil, A.B., and R, C.M., 2011.
Comparison of Disc Diffusion Methods for the Detection of Extended-
Spectrum Beta Lactamase-Producing Enterobacteriaceae. J. Lab.
Physicians /, 3 (1), 1–4.
Giske, C.G., Martinez, L., Cantòn, R., Stefani, S., Skov, R., Glupczynski, Y.,
Nordmann, P., Wootton, M., Miriagou, V., Skov Simonsen, G.,
Zemlickova, H., Cohen-Stuart, J., and Gniadkowski, M., 2013. EUCAST
guidelines for detection of resistance mechanisms and specific resistances
of clinical and / or epidemiological importance. Eur. Soc. Clin. Microbiol.
Infect. Dis., (December), 1–40.
Glupczynski, Y., Berhin, C., Bauraing, C., and Bogaerts, P., 2007. Evaluation of a
new selective chromogenic agar medium for detection of extended-
spectrum beta-lactamase-producing Enterobacteriaceae. J. Clin. Microbiol.,
45 (2), 501–505.
Grohs, P., Tillecovidin, B., Caumont-Prim, A., Carbonnelle, E., Day, N., Podglajen,
I., and Gutmann, L., 2013. Comparison of five media for detection of
extended-spectrum Beta-lactamase by use of the wasp instrument for
automated specimen processing. J. Clin. Microbiol., 51 (8), 2713–6.
Grover, N., Sahni, A.K., and Bhattacharya, S., 2013. Therapeutic challenges of
ESBLS and AmpC beta-lactamase producers in a tertiary care center. Med.
J. Armed Forces India, 69 (1), 4–10.
Harada, S., Ishii, Y., and Yamaguchi, K., 2008. Extended-spectrum beta-
lactamases: implications for the clinical laboratory and therapy. Korean J.
Lab. Med., 28 (6), 401–412.
Huang, T.-D., Bogaerts, P., Berhin, C., Guisset, A., and Glupczynski, Y., 2010.
Evaluation of Brilliance ESBL Agar, a Novel Chromogenic Medium for
Detection of Extended-Spectrum-Beta- Lactamase-Producing
Enterobacteriaceae. J. Clin. Microbiol., 48 (6), 2091–2096.
Jacoby, G.A., 2009. AmpC β -Lactamases. Clin. Microbiol. Rev., 22 (1), 161–182.
Jean B. Patel, Franklin R. Cockerill III, M., Jeff Alder, P., Patricia A. Bradford, P.,
George M. Eliopoulos, M., Dwight J. Hardy, P., Janet A. Hindler, MCLS,
M., Stephen G. Jenkins, PhD, D(ABMM), F., James S. Lewis II, P., Linda
A. Miller, P., Mair Powell, MD, FRCP, Frcp., Jana M. Swenson, Mms.,
Maria M. Traczewski, BS, M., John D. Turnidge, M., Melvin P. Weinstein,
M., and Barbara L. Zimmer, P., 2016. Performance Standards for
Antimicrobial Susceptibility Testing. 26th ed. CLSI supplement M100S.
26th ed. Wayne PA: Clinical Laboratory Standard Institue.
Ji, X., Jin, P., Chu, Y., Feng, S., and Wang, and P., 2014. Clinical Characteristics
and Risk Factors of Diabetic Foot Ulcer With Multidrug- Resistant
Organism Infection. Int. J. Low. Extrem. Wounds, 13 (1), 64–71.
Kader, A.A., Kumar, A., Krishna, A., and Zaman, M.N., 2006. An accelerated
method for the detection of extended-spectrum beta-lactamases in urinary
 119

isolates of Escherichia coli and Klebsiella pneumoniae. Saudi J Kidney Dis

Transpl, 17 (4), 535–539.
King, D.T., Sobhanifar, S., and Strynadka, N.C.J., 2014. The Mechanisms of
Resistance to Beta-Lactam Antibiotics. In: L.E. Cowen, ed. Handbook of
Antimicrobial Resistance. New York: Springer Science, 1–21.
Kolmos, H.J., 2012. Health Care Associated Infections: Sources and Routes of
Transmission. Infect. Control - Updat., 21–38.
Lakshmi, R., Nusrin, K.S., Georgy, S.A., and Sreelakshmi, K.S., 2014. Role of Beta
Lactamases in Antibiotic Resistance: a Review. Int. Res. J. Pharm., 5 (2),
37–40.
Lalitha, M.K., 2004. Manual on Antimicrobial Susceptibility Testing [online].
Microbiology.
Lavery, L.A., Armstrong, D.G., Murdoch, D.P., Peters, E.J.G., and Lipsky, B.A.,
2007. Validation of the Infectious Diseases Society of America ’ s Diabetic
Foot Infection Classification System.
Leverstein-van Hall, M.A., Fluit, A.C., Paauw, A., Box, A.T.A., Brisse, S., and
Verhoef, J., 2002. Evaluation of the Etest ESBL and the BD Phoenix,
VITEK 1, and VITEK 2 automated instruments for detection of extended-
spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella
spp. J. Clin. Microbiol., 40 (10), 3703–3711.
Lipsky, B.A., Berendt, A.R., Cornia, P.B., Pile, J.C., Peters, E.J.G., Armstrong,
D.G., Deery, H.G., Embil, J.M., Joseph, W.S., Karchmer, A.W., Pinzur,
M.S., and Senneville, E., 2012. 2012 Infectious Diseases Society of
America Clinical Practice Guideline for the Diagnosis and Treatment of
Diabetic Foot Infections. Clin. Infect. Dis., 54 (12), 132–173.
Lipsky, B.A., Berendt, A.R., Deery, H.G., Embil, J.M., Joseph, W.S., Karchmer,
A.W., LeFrock, J.L., Lew, D.P., Mader, J.T., Norden, C., and Tan, J.S.,
2004. Diagnosis and Treatment of Diabetic Foot Infections. In: Clinical
Infectious Disease. Seattle: Electronically published, 885–910.
Livermore, D.M., Struelens, M., Amorim, J., Baquero, F., Bille, J., Canton, R.,
Henning, S., Gatermann, S., Marchese, A., Mittermayer, H., Nonhoff, C.,
Oakton, K.J., Praplan, F., Ramos, H., Schito, G.C., Van Eldere, J.,
Verhaegen, J., Verhoef, J., and Visser, M.R., 2002. Multicentre evaluation
of the VITEK 2 Advanced Expert System for interpretive reading of
antimicrobial resistance tests. J. Antimicrob. Chemother., 49 (2), 289–300.
Longdong J.B., Dahesihdewi A, Suwarso. Prevalensi dan Faktor Risiko Infeksi
Ulkus Kaki Diabetik oleh Organisme Resisten Multi Obat di RSUP Dr.
Sardjito Yogyakarta. Naskah Tesis MS, 2016
Madiyono, Moeslichan, S.M., Sastroasmoro, S., Budiman, I., and Purwanto, S.H.,
2010. Perkiraan Besar Sampel. In: S. Sastroasmoro and S. Ismael, eds.
Dasar-dasar Metodologi Penelitian Klinis. Jakarta: CV Sagung Seto, 302–
331.
Mahon, C.R., Lehman, D.C., and Manuselis, G., 2011. Textbook of Diagnostic
Microbiology. 4th ed. Missouri: Saunders Elsevier.
Maremanda, V.D., Gowda, D. V, Shanmukha, K., Raghunandan, H.V., and Reddy,
P., 2014. Complications and risk management of diabetic foot ulcer : A
 120

review. J. Sci. Innov. Res., 3 (November), 363–371.

Mendes, J. and Neves, J., 2012. Diabetic Foot Infections: Current Diagnosis and
Treatment. J. Diabet. Foot Complicat., 4 (2), 26–45.
Mendes, J.J., Marques-Costa, A., Vilela, C., Neves, J., Candeias, N., Cavaco-Silva,
P., and Melo-Cristino, J., 2012. Clinical and bacteriological survey of
diabetic foot infections in Lisbon. Diabetes Res. Clin. Pract., 95 (1), 153–
161.
Merlino, J., 2010. Applications and integration of chromogenic culture media in
clinical microbiology, (September), 127–130.
Murali, T.S., Kavitha, S., Spoorthi, J., Bhat, D. V, Prasad, A.S.B., Upton, Z.,
Ramachandra, L., Acharya, R. V, and Satyamoorthy, K., 2014.
Characteristics of microbial drug resistance and its correlates in chronic
diabetic foot ulcer infections Isolation of bacteria. J. Med. Microbiol., 63
(2014), 1377–1385.
Nas, 2016. Prevalensi dan Faktor Risiko Infeksi Ulkus Kaki Diabetik Oleh
Organisme Resisten Multi Obat Prevalensi dan Faktor Risiko Infeksi Ulkus
Kaki Diabetik Oleh Organisme Resisten Multi Obat di RSUP Dr . Sardjito
Yogyakarta. Gadjah Mada.
Noor, S., Zubair, M., and Ahmad, J., 2015. Diabetic foot ulcer - A review on
pathophysiology, classification and microbial etiology. Diab. Metab. Syndr.
Clin. Res. Rev., 9 (3), 192–199.
Paterson, D.L. and Bonomo, R.A., 2005. Extended-Spectrum β-Lactamases: a
Clinical Update. Clin. Microbiol. Rev., 18 (4), 657–686.
Paul G. Engelkirk and Janet Duben-Engelkrik, 2008. Laboratory Diagnosis of
Infection Diseases : Essentials of Diagnostic Microbiology. Laboratory
Diagnosis of Infection Diseases : Essentials of Diagnostic Microbiology.
Philadelpia: Lippincott Williams and Wilkins.
Perry, J.D., 2017. A Decade of Development of Chromogenic Culture Media for
Clinical Microbiology in an Era of Molecular Diagnostics. Clin. Microbiol.
Rev., 30 (2), 449–479.
Perry, J.D. and Freydière, A.M., 2007. The application of chromogenic media in
clinical microbiology. J. Appl. Microbiol., 103 (6), 2046–2055.
Perry, J.D., Morris, K.A., James, A.L., Oliver, M., and Gould, F.K., 2007.
Evaluation of novel chromogenic substrates for the detection of bacterial ??-
glucosidase. J. Appl. Microbiol., 102 (2), 410–415.
Pincus, D.H., 2010. Microbial identification using the bioMérieux VITEK® 2
system. Encycl. Rapid Microbiol. Methods, 1–32.
Pitout, J.D.D., Nordmann, P., Laupland, K.B., and Poirel, L., 2005. Emergence of
Enterobacteriaceae producing extended-spectrum -lactamases (ESBLs) in
the community. J. Antimicrob. Chemother., 56 (1), 52–59.
Rambach., A., 2009. Chromogenic Technology [online]. diunduh dari
http//www.chromagar.com/p-Chromogenic_agar_Technology.html.
Rao, P.N.S., 2015. Extended Spectrum Beta Lactamases- A Comprehensive
Review.
Rawat, D. and Nair, D., 2010. Extended-spectrum beta-lactamases in Gram
Negative Bacteria. J. Glob. Infect. Dis. This, 2 (3), 263–274.
 121

Richard, J.-L., Sotto, A., and Lavigne, J.-P., 2011. New insights in diabetic foot
infection. World J. Diabetes, 2 (2), 24–32.
Richard, J.L., Sotto, A., Jourdan, N., Combescure, C., Vannereau, D., Rodier, M.,
and Lavigne, J.P., 2008. Risk factors and healing impact of multidrug-
resistant bacteria in diabetic foot ulcers. Diabetes Metab., 34 (4), 363–369.
Roberts, A.D. and Simon, G.L., 2012. Diabetic Foot Infections: The Role of
Microbiology and Antibiotic Treatment. Semin. Vasc. Surg., 25 (2), 75–81.
Rodrigues, J. and Mitta, N., 2011. Diabetic Foot and Gangrene. In: A. Vitin, ed.
Gangrene - Current Concepts and Management Options. Shanghai: InTech
China, 121–144.
Rupp, M.E. and Fey, P.D., 2003. Extended Spectrum Beta-Lactamase (ESBL)-
Producing Enterobacteriaceae: Considerations for Diagnosis, Prevention
and Drug Treatment. Drugs, 63 (4), 353–365.
Sastroasmoro, S., Gatot, D., Kadri, N., and Pudjiarto, P.S., 2014. Usulan Penelitian.
In: S. Sastroasmoro and S. Ismael, eds. Dasar-dasar Metodologi Penelitian
Klinis. Jakarta: Sagung Seto, 31–64.
Shahi, S., Kumar, a, Kumar, S., Singh, S., Gupta, S., and Singh, T., 2012.
Prevalence of Diabetic Foot Ulcer and Associated Risk Factors in Diabetic
Patients From North India. J. Diabet. Foot Complicat., 4 (3 (4)), 83–91.
Shahid, M., Malik, A., Agrawal, M., and Singhal, S., 2004. Phenotypic detection of
extended-spectrum and AmpC beta-lactamases by a new spot-inoculation
method and modified three-dimensional extract test: Comparison with the
conventional three-dimensional extract test. J. Antimicrob. Chemother., 54
(3), 684–687.
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S.M.D., and Kamal, M.A., 2015. Antibiotic
resistance and extended spectrum beta-lactamases: Types, epidemiology
and treatment. Saudi J. Biol. Sci., 22 (1), 90–101.
Shanmugam, P., Jeya, M., and Susan, L., 2013. The Bacteriology of Diabetic Foot
Ulcers, with a Special Reference to Multidrug Resistant Strains. J. Clin.
Diag. Res., 7 (3), 441–5.
Siegel, J.D., Rhinehart, E., Cic, R.N.M.P.H., Jackson, M., Brennan, P.J., and Bell,
M., 2006. Management of Multidrug-Resistant Organisms In Healthcare
Settings [online]. Centers Dis. Control Prev.
Simundic, A.-M., 2009. Measures of diagnostic accuracy : basic definitions. J. Int.
Fed. Clin. Chem. Lab. Med., 19 (4), 1–9.
Singh, S., Pai, D.R., and Yuhhui, C., 2013. Diabetic Foot Ulcer – Diagnosis and
Management. Clin. Res. Foot Ankle, 1 (3), 1–9.
Spanu, T., Sanguinetti, M., Tumbarello, M., Inzeo, T.D., Fiori, B., Posteraro, B.,
Santangelo, R., Cauda, R., and Fadda, G., 2006. Evaluation of the New
VITEK 2 Extended-Spectrum Beta-Lactamase ( ESBL ) Test for Rapid
Detection of ESBL Production in Enterobacteriaceae Isolates. J. Clin.
Microbiol., 44 (9), 3257–3262.
Spear, B.M., 2014. When and how to culture a chronic wound [online]. Wound Care
Advis.
Spichler, A., Hurwitz, B.L., Armstrong, D.G., and Lipsky, B.A., 2015.
Microbiology of diabetic foot infections: from Louis Pasteur to ‘crime scene
 122

investigation’. BMC Med., 13, 2.

Stürenburg, E. and Mack, D., 2003. Extended-spectrum β-lactamases: Implications
for the clinical microbiology laboratory, therapy, and infection control. J.
Infect., 47 (4), 273–295.
Svärd, L., 2007. Evaluation of Phenotypic and Genotypic Detection methods.
Dublin.
Thermo scientific, 2017. Product Specification Sheet. diunduh dari :
http://www.avantec.fr/content/dam/tfs/SDG/MBD/MBD%20Documents/C
atalogs%20&%20Brochures/Specification%20Sheets/PO/PO5302A.pdf.
Thomson, K.S., 2010. Extended-spectrum-Beta-lactamase, AmpC, and
carbapenemase issues. J. Clin. Microbiol., 48 (4), 1019–1025.
Trivedi, U., Parameswaran, S., Armstrong, A., Burgueno-Vega, D., Griswold, J.,
Dissanaike, S., and Rumbaugh, K.P., 2014. Prevalence of Multiple
Antibiotic Resistant Infections in Diabetic versus Nondiabetic Wounds. J.
Pathog., 2014, 1–6.
Uckay, I., Aragon-Sanches, J., Lew, D., and Lipsky, B.A., 2015. Diabetic foot
infections: What have we learned in the last 30 years? Int. J. Infect. Dis., 40,
81–91.
Vandepitte, J., Verhaegen, J., Engbaek, K., Rohner, P., Piot, P., and Hueck, C.C.,
2003. Basic Laboratory Procedures in Clinical Bacteriology [online]. Basic
Lab. Proced. Clin. Bacteriol.
Viera, A.J. and Garrett, J.M., 2005. Understanding Interobserver Agreement: The
Kappa Statistic. Fam. Med., 37 (May), 360–363.
Vosough, M., 2010. An Article on Chromogenic Media. diunduh dari
http://www.condalab.com/pdf/Bahar_casestudy.pdf.
Wahab, N. hilda H.A., Samsudin, I.N., Nordin, S.A., Ahmad, Z., Noor, L.A.M., and
Devnani, A.S., 2015. Clinical presentation and microorganisms sensitivity
profile for diabetic foot ulcers: A pilot study. Med. J. Malaysia, 70 (3), 182–
187.
Willems, E., Cartuyvels, R., Magerman, K., and Verhaegen, J., 2013. Evaluation of
3 different agar media for rapid detection of extended-spectrum β -
lactamase – producing Enterobacteriaceae from surveillance samples.
Diagn. Microbiol. Infect. Dis., 76 (1), 16–19.
Willems, E., Verhaegen, J., Magerman, K., Nys, S., and Cartuyvels, R., 2013.
Towards a phenotypic screening strategy for emerging β-lactamases in
Gram-negative bacilli. Int. J. Antimicrob. Agents, 41 (2), 99–109.
Zubair, M., Malik, A., and Ahmad, J., 2010. Clinico-microbiological study and
antimicrobial drug resistance profile of diabetic foot infections in North
India. Foot, 21 (1), 6–14.